Monday, February 8, 2021

Illumina Accelerator Makes Investments In Nine Startups

San Diego-based life sciences equipment giant Illumina said today that it has made investments in nine new genomics companies, as part of the company's startup accelerator, the Illumina Accelerator. The company said it made investments in four companies for its effort in the UK, and five companies at its accelerator in the Bay Area. Illumina said the startups receiving investments in the UK included BiotaX Labs LTD, Broken String Biosciences Limited, Mitra Bio Limited, and MultiplAI Health LTD. The companies in the Bay Area were Doloromics (Dallas), Flightpath Biosciences (Berkeley), Oshun Medical (SF Bar Area); Parallel health (SF Bay Area), and Rubik Therapeutics (Boston). The accelerator said it is accepting application for its next funding cycle until March 1st.